Start for free
Start for free
AZ

Alice Zhang

North America, California, United States, San Francisco

Description

Alice Zhang is the CEO and Co-founder at Verge Genomics.

Investor Profile

Alice Zhang has made 13 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (54%)
  • Series A (38%)
  • Pre Seed (8%)

Country Focus

  • United States (92%)
  • United Kingdom (8%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Mental Health
  • Machine Learning
  • Manufacturing
  • Personal Health
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alice Zhang frequently co-invest with?

Arkitekt Ventures
Arkitekt Ventures
North America, New York, United States, New York
Co-Investments: 2
General Catalyst
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Y Combinator
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 3
Boost VC
Boost VC
North America, California, United States, San Mateo
Co-Investments: 2
SV Angel
SV Angel
North America, California, United States, San Francisco
Co-Investments: 3
Fifty Years
Fifty Years
North America, California, United States, San Francisco
Co-Investments: 4
Lux Capital
Lux Capital
North America, New York, United States, New York
Co-Investments: 4
Maverick Ventures
Maverick Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Village Global
Village Global
North America, California, United States, Covina
Co-Investments: 3
Khosla Ventures
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 3

Which angels does Alice Zhang often collaborate with?

CH
Chris Hsu
North America, Nevada, United States, Reno
Shared Deals: 1
DB
Dina Burkitbayeva
North America, California, United States, San Francisco
Shared Deals: 1
AY
Ashley Yesayan
North America, District of Columbia, United States, Washington
Shared Deals: 1
BT
Beth Turner
North America, California, United States, San Francisco
Shared Deals: 1
CM
Chris Mansi
North America, California, United States, San Francisco
Shared Deals: 1
EC
Ellen Chisa
North America, California, United States, San Francisco
Shared Deals: 1
AD
Ariel Dora Stern
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
MA
Milad Alucozai
North America, California, United States, San Francisco
Shared Deals: 2
Alyssa Atkins
Alyssa Atkins
North America, Ontario, Canada, Toronto
Shared Deals: 1
Deon Nicholas
Deon Nicholas
North America, California, United States
Shared Deals: 1

What are some of recent deals done by Alice Zhang?

Ochre Bio

Oxford, Oxfordshire, United Kingdom

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AOct 10, 2022
Amount Raised: $30,000,000
Arpeggio Bio

Boulder, Colorado, United States

Arpeggio builds technology to watch and learn how drugs work.

BiotechnologyHealth CareMachine LearningPharmaceuticalTherapeutics
Series ASep 7, 2022
Amount Raised: $17,000,000
Osmind

San Francisco, California, United States

Osmind is the premier technology platform for breakthough mental health treatment and research.

Health CareMedicalMental Health
Series AJul 1, 2021
Amount Raised: $15,000,000
HumanFirst

San Francisco, California, United States

HumanFirst accelerates the adoption of patient-centered clinical trials using precision digital measures (e.g., digital biomarkers and eCOA)

Health Care
Series AMay 31, 2021
Amount Raised: $12,000,000
Multiply Labs

San Francisco, California, United States

Multiply Labs deploys advanced robotics technology to manufacture personalized pharmaceutical capsules.

Industrial AutomationManufacturingPersonal HealthPharmaceuticalRobotics
Series AApr 14, 2021
Amount Raised: $20,000,000
64x Bio

San Francisco, California, United States

64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.

BiopharmaBiotechnologyGeneticsLife SciencePharmaceutical
SeedNov 16, 2020
Amount Raised: $4,500,000
Osmind

San Francisco, California, United States

Osmind is the premier technology platform for breakthough mental health treatment and research.

Health CareMedicalMental Health
SeedOct 14, 2020
Amount Raised: $2,000,000
Arpeggio Bio

Boulder, Colorado, United States

Arpeggio builds technology to watch and learn how drugs work.

BiotechnologyHealth CareMachine LearningPharmaceuticalTherapeutics
SeedJan 15, 2020
Amount Raised: $3,200,000
HumanFirst

San Francisco, California, United States

HumanFirst accelerates the adoption of patient-centered clinical trials using precision digital measures (e.g., digital biomarkers and eCOA)

Health Care
SeedNov 12, 2019
Amount Raised: $2,900,000
Asher Bio

San Francisco, California, United States

Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.

BiotechnologyTherapeutics
Pre SeedAug 19, 2019
Amount Raised: $150,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator